Metraipolis › archive › dc_fea7ca49a332

Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42404219
DOI
10.3389/fonc.2026.1819733
License (as archived)
solo-consultazione
Archived
2026-10-19T07:43:49.059Z
SHA-256 of the archived text
ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a
Stable URL of this page
https://metraipolis.com/documento/dc_fea7ca49a332

How to cite

Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219 — Europe PMC (en), https://europepmc.org/article/MED/42404219 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea7ca49a332 (Metraipolis archive dc_fea7ca49a332, sha256 ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a)
BibTeX
@misc{dcfea7ca49a332,
  title = {Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42404219},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea7ca49a332; sha256 ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42404219. Agents can read the archived copy with the MCP tool read_document.